Global Custom Antibody Market

Custom Antibody Comprehensive Study by Type (Monoclonal, Polyclonal, Recombinant), End-Users (Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), Service (Antibody Production, Characterization, Immunization, Fragmentation), Research Area (Oncology, Immunology), Source (Mouse, Rabbit) Players and Region - Global Market Outlook to 2026

Custom Antibody Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 8.88%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Custom Antibody Market Scope
Custom antibody provides high specificity & selectivity, these antibodies are easy to produce as compared to other antibodies & are hence the preferred choice in all types of research studies. Factors such as increasing research activity in life sciences industry along with increasing associations between industry & academic centers is driving the growth of the custom antibody market.one of the best benefit of custom antibody is that it accomplishes well in a qualitative or quantitative immuno detection method. The quality of catalog antibodies is also an area of concern in this market, & henceforth end users prefer custom-made antibodies.

According to AMA, the Global Custom Antibody market is expected to see growth rate of 8.88% and may see market size of USD480.96 Million by 2026.

Key players are adopting numerous strategy to gain market attention and to increase their market share, this strategy can be listed as increasing product portfolio, making partnership to adopt certain technologies and acquiring small players to finish competition in the future. As well as investing money in R&D sector to make up-gradations and innovation in product. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Custom Antibody market throughout the predicted period.

Thermo Fisher Scientific Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Merck Group (Germany), Abcam plc (United Kingdom), Cell Signaling Technology, Inc. (United States), Agilent Technologies, Inc. (United States), GenScript (United States), BioLegend, Inc. (United States), Rockland Immunochemicals (United States) and ProMab Biotechnologies (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Innovagen AB (Sweden), ProteoGenix (United States) and Abgent (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Custom Antibody market by Type (Monoclonal, Polyclonal and Recombinant) and Region with country level break-up.

On the basis of geography, the market of Custom Antibody has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Prominent players are involved in new product launch by collaborating with other companies, I.e. Abcam launched the (PBS)-only recombinant antibodies and the new anti-PD-L1 antibody clone MKP1A07310 (clone 73-10) developed in collaboration with Merck KGaA in 2018


Market Trend
  • Growing Industry-Academia Collaborations for Research Purpose
  • Increasing Focus on Antibody-Drug Conjugates (ADCS)
  • Development of Bispecific Antibodies

Market Drivers
  • Continuously Growing Research Activity and Related Funding
  • Quality Concerns Over Catalog Antibodies
  • Increasing Antibody Therapeutics and Expanding Drug Pipeline

Opportunities
  • High Growth Opportunities in Emerging Countries
  • Increasing Demand for Personalized Medicine and Protein Therapeutics

Restraints
  • Growth in Stem Cell and Cvd Research
  • Increasing Focus on Biomarker Discovery

Challenges
  • Availability of the substitutes
  • Cost- and Time-Intensive Antibody Development Processes


Key Target Audience
Antibiotics manufacturer, Raw material supplier, Traders/Distributors/Dealer, Industry Association, Governments and investment communities and Research organizations and associations

Report Objectives / Segmentation Covered

By Type
  • Monoclonal
  • Polyclonal
  • Recombinant
By End-Users
  • Hospitals and Clinics
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

By Service
  • Antibody Production
  • Characterization
  • Immunization
  • Fragmentation

By Research Area
  • Oncology
  • Immunology

By Source
  • Mouse
  • Rabbit

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Continuously Growing Research Activity and Related Funding
      • 3.2.2. Quality Concerns Over Catalog Antibodies
      • 3.2.3. Increasing Antibody Therapeutics and Expanding Drug Pipeline
    • 3.3. Market Challenges
      • 3.3.1. Availability of the substitutes
      • 3.3.2. Cost- and Time-Intensive Antibody Development Processes
    • 3.4. Market Trends
      • 3.4.1. Growing Industry-Academia Collaborations for Research Purpose
      • 3.4.2. Increasing Focus on Antibody-Drug Conjugates (ADCS)
      • 3.4.3. Development of Bispecific Antibodies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Custom Antibody, by Type, End-Users, Service, Research Area, Source and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Custom Antibody (Value)
      • 5.2.1. Global Custom Antibody by: Type (Value)
        • 5.2.1.1. Monoclonal
        • 5.2.1.2. Polyclonal
        • 5.2.1.3. Recombinant
      • 5.2.2. Global Custom Antibody by: End-Users (Value)
        • 5.2.2.1. Hospitals and Clinics
        • 5.2.2.2. Pharmaceutical & Biotechnology Companies
        • 5.2.2.3. Academic & Research Institutes
        • 5.2.2.4. Contract Research Organizations
      • 5.2.3. Global Custom Antibody by: Service (Value)
        • 5.2.3.1. Antibody Production
        • 5.2.3.2. Characterization
        • 5.2.3.3. Immunization
        • 5.2.3.4. Fragmentation
      • 5.2.4. Global Custom Antibody by: Research Area (Value)
        • 5.2.4.1. Oncology
        • 5.2.4.2. Immunology
      • 5.2.5. Global Custom Antibody by: Source (Value)
        • 5.2.5.1. Mouse
        • 5.2.5.2. Rabbit
      • 5.2.6. Global Custom Antibody Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Custom Antibody: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Group (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abcam plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cell Signaling Technology, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GenScript (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BioLegend, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Rockland Immunochemicals (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ProMab Biotechnologies (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Custom Antibody Sale, by Type, End-Users, Service, Research Area, Source and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Custom Antibody (Value)
      • 7.2.1. Global Custom Antibody by: Type (Value)
        • 7.2.1.1. Monoclonal
        • 7.2.1.2. Polyclonal
        • 7.2.1.3. Recombinant
      • 7.2.2. Global Custom Antibody by: End-Users (Value)
        • 7.2.2.1. Hospitals and Clinics
        • 7.2.2.2. Pharmaceutical & Biotechnology Companies
        • 7.2.2.3. Academic & Research Institutes
        • 7.2.2.4. Contract Research Organizations
      • 7.2.3. Global Custom Antibody by: Service (Value)
        • 7.2.3.1. Antibody Production
        • 7.2.3.2. Characterization
        • 7.2.3.3. Immunization
        • 7.2.3.4. Fragmentation
      • 7.2.4. Global Custom Antibody by: Research Area (Value)
        • 7.2.4.1. Oncology
        • 7.2.4.2. Immunology
      • 7.2.5. Global Custom Antibody by: Source (Value)
        • 7.2.5.1. Mouse
        • 7.2.5.2. Rabbit
      • 7.2.6. Global Custom Antibody Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Custom Antibody: by Type(USD Million)
  • Table 2. Custom Antibody Monoclonal , by Region USD Million (2015-2020)
  • Table 3. Custom Antibody Polyclonal , by Region USD Million (2015-2020)
  • Table 4. Custom Antibody Recombinant , by Region USD Million (2015-2020)
  • Table 5. Custom Antibody: by End-Users(USD Million)
  • Table 6. Custom Antibody Hospitals and Clinics , by Region USD Million (2015-2020)
  • Table 7. Custom Antibody Pharmaceutical & Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 8. Custom Antibody Academic & Research Institutes , by Region USD Million (2015-2020)
  • Table 9. Custom Antibody Contract Research Organizations , by Region USD Million (2015-2020)
  • Table 10. Custom Antibody: by Service(USD Million)
  • Table 11. Custom Antibody Antibody Production , by Region USD Million (2015-2020)
  • Table 12. Custom Antibody Characterization , by Region USD Million (2015-2020)
  • Table 13. Custom Antibody Immunization , by Region USD Million (2015-2020)
  • Table 14. Custom Antibody Fragmentation , by Region USD Million (2015-2020)
  • Table 15. Custom Antibody: by Research Area(USD Million)
  • Table 16. Custom Antibody Oncology , by Region USD Million (2015-2020)
  • Table 17. Custom Antibody Immunology , by Region USD Million (2015-2020)
  • Table 18. Custom Antibody: by Source(USD Million)
  • Table 19. Custom Antibody Mouse , by Region USD Million (2015-2020)
  • Table 20. Custom Antibody Rabbit , by Region USD Million (2015-2020)
  • Table 21. South America Custom Antibody, by Country USD Million (2015-2020)
  • Table 22. South America Custom Antibody, by Type USD Million (2015-2020)
  • Table 23. South America Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 24. South America Custom Antibody, by Service USD Million (2015-2020)
  • Table 25. South America Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 26. South America Custom Antibody, by Source USD Million (2015-2020)
  • Table 27. Brazil Custom Antibody, by Type USD Million (2015-2020)
  • Table 28. Brazil Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 29. Brazil Custom Antibody, by Service USD Million (2015-2020)
  • Table 30. Brazil Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 31. Brazil Custom Antibody, by Source USD Million (2015-2020)
  • Table 32. Argentina Custom Antibody, by Type USD Million (2015-2020)
  • Table 33. Argentina Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 34. Argentina Custom Antibody, by Service USD Million (2015-2020)
  • Table 35. Argentina Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 36. Argentina Custom Antibody, by Source USD Million (2015-2020)
  • Table 37. Rest of South America Custom Antibody, by Type USD Million (2015-2020)
  • Table 38. Rest of South America Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 39. Rest of South America Custom Antibody, by Service USD Million (2015-2020)
  • Table 40. Rest of South America Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 41. Rest of South America Custom Antibody, by Source USD Million (2015-2020)
  • Table 42. Asia Pacific Custom Antibody, by Country USD Million (2015-2020)
  • Table 43. Asia Pacific Custom Antibody, by Type USD Million (2015-2020)
  • Table 44. Asia Pacific Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 45. Asia Pacific Custom Antibody, by Service USD Million (2015-2020)
  • Table 46. Asia Pacific Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 47. Asia Pacific Custom Antibody, by Source USD Million (2015-2020)
  • Table 48. China Custom Antibody, by Type USD Million (2015-2020)
  • Table 49. China Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 50. China Custom Antibody, by Service USD Million (2015-2020)
  • Table 51. China Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 52. China Custom Antibody, by Source USD Million (2015-2020)
  • Table 53. Japan Custom Antibody, by Type USD Million (2015-2020)
  • Table 54. Japan Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 55. Japan Custom Antibody, by Service USD Million (2015-2020)
  • Table 56. Japan Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 57. Japan Custom Antibody, by Source USD Million (2015-2020)
  • Table 58. India Custom Antibody, by Type USD Million (2015-2020)
  • Table 59. India Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 60. India Custom Antibody, by Service USD Million (2015-2020)
  • Table 61. India Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 62. India Custom Antibody, by Source USD Million (2015-2020)
  • Table 63. South Korea Custom Antibody, by Type USD Million (2015-2020)
  • Table 64. South Korea Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 65. South Korea Custom Antibody, by Service USD Million (2015-2020)
  • Table 66. South Korea Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 67. South Korea Custom Antibody, by Source USD Million (2015-2020)
  • Table 68. Taiwan Custom Antibody, by Type USD Million (2015-2020)
  • Table 69. Taiwan Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 70. Taiwan Custom Antibody, by Service USD Million (2015-2020)
  • Table 71. Taiwan Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 72. Taiwan Custom Antibody, by Source USD Million (2015-2020)
  • Table 73. Australia Custom Antibody, by Type USD Million (2015-2020)
  • Table 74. Australia Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 75. Australia Custom Antibody, by Service USD Million (2015-2020)
  • Table 76. Australia Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 77. Australia Custom Antibody, by Source USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific Custom Antibody, by Type USD Million (2015-2020)
  • Table 79. Rest of Asia-Pacific Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 80. Rest of Asia-Pacific Custom Antibody, by Service USD Million (2015-2020)
  • Table 81. Rest of Asia-Pacific Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 82. Rest of Asia-Pacific Custom Antibody, by Source USD Million (2015-2020)
  • Table 83. Europe Custom Antibody, by Country USD Million (2015-2020)
  • Table 84. Europe Custom Antibody, by Type USD Million (2015-2020)
  • Table 85. Europe Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 86. Europe Custom Antibody, by Service USD Million (2015-2020)
  • Table 87. Europe Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 88. Europe Custom Antibody, by Source USD Million (2015-2020)
  • Table 89. Germany Custom Antibody, by Type USD Million (2015-2020)
  • Table 90. Germany Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 91. Germany Custom Antibody, by Service USD Million (2015-2020)
  • Table 92. Germany Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 93. Germany Custom Antibody, by Source USD Million (2015-2020)
  • Table 94. France Custom Antibody, by Type USD Million (2015-2020)
  • Table 95. France Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 96. France Custom Antibody, by Service USD Million (2015-2020)
  • Table 97. France Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 98. France Custom Antibody, by Source USD Million (2015-2020)
  • Table 99. Italy Custom Antibody, by Type USD Million (2015-2020)
  • Table 100. Italy Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 101. Italy Custom Antibody, by Service USD Million (2015-2020)
  • Table 102. Italy Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 103. Italy Custom Antibody, by Source USD Million (2015-2020)
  • Table 104. United Kingdom Custom Antibody, by Type USD Million (2015-2020)
  • Table 105. United Kingdom Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 106. United Kingdom Custom Antibody, by Service USD Million (2015-2020)
  • Table 107. United Kingdom Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 108. United Kingdom Custom Antibody, by Source USD Million (2015-2020)
  • Table 109. Netherlands Custom Antibody, by Type USD Million (2015-2020)
  • Table 110. Netherlands Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 111. Netherlands Custom Antibody, by Service USD Million (2015-2020)
  • Table 112. Netherlands Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 113. Netherlands Custom Antibody, by Source USD Million (2015-2020)
  • Table 114. Rest of Europe Custom Antibody, by Type USD Million (2015-2020)
  • Table 115. Rest of Europe Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 116. Rest of Europe Custom Antibody, by Service USD Million (2015-2020)
  • Table 117. Rest of Europe Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 118. Rest of Europe Custom Antibody, by Source USD Million (2015-2020)
  • Table 119. MEA Custom Antibody, by Country USD Million (2015-2020)
  • Table 120. MEA Custom Antibody, by Type USD Million (2015-2020)
  • Table 121. MEA Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 122. MEA Custom Antibody, by Service USD Million (2015-2020)
  • Table 123. MEA Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 124. MEA Custom Antibody, by Source USD Million (2015-2020)
  • Table 125. Middle East Custom Antibody, by Type USD Million (2015-2020)
  • Table 126. Middle East Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 127. Middle East Custom Antibody, by Service USD Million (2015-2020)
  • Table 128. Middle East Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 129. Middle East Custom Antibody, by Source USD Million (2015-2020)
  • Table 130. Africa Custom Antibody, by Type USD Million (2015-2020)
  • Table 131. Africa Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 132. Africa Custom Antibody, by Service USD Million (2015-2020)
  • Table 133. Africa Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 134. Africa Custom Antibody, by Source USD Million (2015-2020)
  • Table 135. North America Custom Antibody, by Country USD Million (2015-2020)
  • Table 136. North America Custom Antibody, by Type USD Million (2015-2020)
  • Table 137. North America Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 138. North America Custom Antibody, by Service USD Million (2015-2020)
  • Table 139. North America Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 140. North America Custom Antibody, by Source USD Million (2015-2020)
  • Table 141. United States Custom Antibody, by Type USD Million (2015-2020)
  • Table 142. United States Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 143. United States Custom Antibody, by Service USD Million (2015-2020)
  • Table 144. United States Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 145. United States Custom Antibody, by Source USD Million (2015-2020)
  • Table 146. Canada Custom Antibody, by Type USD Million (2015-2020)
  • Table 147. Canada Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 148. Canada Custom Antibody, by Service USD Million (2015-2020)
  • Table 149. Canada Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 150. Canada Custom Antibody, by Source USD Million (2015-2020)
  • Table 151. Mexico Custom Antibody, by Type USD Million (2015-2020)
  • Table 152. Mexico Custom Antibody, by End-Users USD Million (2015-2020)
  • Table 153. Mexico Custom Antibody, by Service USD Million (2015-2020)
  • Table 154. Mexico Custom Antibody, by Research Area USD Million (2015-2020)
  • Table 155. Mexico Custom Antibody, by Source USD Million (2015-2020)
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Custom Antibody: by Type(USD Million)
  • Table 167. Custom Antibody Monoclonal , by Region USD Million (2021-2026)
  • Table 168. Custom Antibody Polyclonal , by Region USD Million (2021-2026)
  • Table 169. Custom Antibody Recombinant , by Region USD Million (2021-2026)
  • Table 170. Custom Antibody: by End-Users(USD Million)
  • Table 171. Custom Antibody Hospitals and Clinics , by Region USD Million (2021-2026)
  • Table 172. Custom Antibody Pharmaceutical & Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 173. Custom Antibody Academic & Research Institutes , by Region USD Million (2021-2026)
  • Table 174. Custom Antibody Contract Research Organizations , by Region USD Million (2021-2026)
  • Table 175. Custom Antibody: by Service(USD Million)
  • Table 176. Custom Antibody Antibody Production , by Region USD Million (2021-2026)
  • Table 177. Custom Antibody Characterization , by Region USD Million (2021-2026)
  • Table 178. Custom Antibody Immunization , by Region USD Million (2021-2026)
  • Table 179. Custom Antibody Fragmentation , by Region USD Million (2021-2026)
  • Table 180. Custom Antibody: by Research Area(USD Million)
  • Table 181. Custom Antibody Oncology , by Region USD Million (2021-2026)
  • Table 182. Custom Antibody Immunology , by Region USD Million (2021-2026)
  • Table 183. Custom Antibody: by Source(USD Million)
  • Table 184. Custom Antibody Mouse , by Region USD Million (2021-2026)
  • Table 185. Custom Antibody Rabbit , by Region USD Million (2021-2026)
  • Table 186. South America Custom Antibody, by Country USD Million (2021-2026)
  • Table 187. South America Custom Antibody, by Type USD Million (2021-2026)
  • Table 188. South America Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 189. South America Custom Antibody, by Service USD Million (2021-2026)
  • Table 190. South America Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 191. South America Custom Antibody, by Source USD Million (2021-2026)
  • Table 192. Brazil Custom Antibody, by Type USD Million (2021-2026)
  • Table 193. Brazil Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 194. Brazil Custom Antibody, by Service USD Million (2021-2026)
  • Table 195. Brazil Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 196. Brazil Custom Antibody, by Source USD Million (2021-2026)
  • Table 197. Argentina Custom Antibody, by Type USD Million (2021-2026)
  • Table 198. Argentina Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 199. Argentina Custom Antibody, by Service USD Million (2021-2026)
  • Table 200. Argentina Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 201. Argentina Custom Antibody, by Source USD Million (2021-2026)
  • Table 202. Rest of South America Custom Antibody, by Type USD Million (2021-2026)
  • Table 203. Rest of South America Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 204. Rest of South America Custom Antibody, by Service USD Million (2021-2026)
  • Table 205. Rest of South America Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 206. Rest of South America Custom Antibody, by Source USD Million (2021-2026)
  • Table 207. Asia Pacific Custom Antibody, by Country USD Million (2021-2026)
  • Table 208. Asia Pacific Custom Antibody, by Type USD Million (2021-2026)
  • Table 209. Asia Pacific Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 210. Asia Pacific Custom Antibody, by Service USD Million (2021-2026)
  • Table 211. Asia Pacific Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 212. Asia Pacific Custom Antibody, by Source USD Million (2021-2026)
  • Table 213. China Custom Antibody, by Type USD Million (2021-2026)
  • Table 214. China Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 215. China Custom Antibody, by Service USD Million (2021-2026)
  • Table 216. China Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 217. China Custom Antibody, by Source USD Million (2021-2026)
  • Table 218. Japan Custom Antibody, by Type USD Million (2021-2026)
  • Table 219. Japan Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 220. Japan Custom Antibody, by Service USD Million (2021-2026)
  • Table 221. Japan Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 222. Japan Custom Antibody, by Source USD Million (2021-2026)
  • Table 223. India Custom Antibody, by Type USD Million (2021-2026)
  • Table 224. India Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 225. India Custom Antibody, by Service USD Million (2021-2026)
  • Table 226. India Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 227. India Custom Antibody, by Source USD Million (2021-2026)
  • Table 228. South Korea Custom Antibody, by Type USD Million (2021-2026)
  • Table 229. South Korea Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 230. South Korea Custom Antibody, by Service USD Million (2021-2026)
  • Table 231. South Korea Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 232. South Korea Custom Antibody, by Source USD Million (2021-2026)
  • Table 233. Taiwan Custom Antibody, by Type USD Million (2021-2026)
  • Table 234. Taiwan Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 235. Taiwan Custom Antibody, by Service USD Million (2021-2026)
  • Table 236. Taiwan Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 237. Taiwan Custom Antibody, by Source USD Million (2021-2026)
  • Table 238. Australia Custom Antibody, by Type USD Million (2021-2026)
  • Table 239. Australia Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 240. Australia Custom Antibody, by Service USD Million (2021-2026)
  • Table 241. Australia Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 242. Australia Custom Antibody, by Source USD Million (2021-2026)
  • Table 243. Rest of Asia-Pacific Custom Antibody, by Type USD Million (2021-2026)
  • Table 244. Rest of Asia-Pacific Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 245. Rest of Asia-Pacific Custom Antibody, by Service USD Million (2021-2026)
  • Table 246. Rest of Asia-Pacific Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 247. Rest of Asia-Pacific Custom Antibody, by Source USD Million (2021-2026)
  • Table 248. Europe Custom Antibody, by Country USD Million (2021-2026)
  • Table 249. Europe Custom Antibody, by Type USD Million (2021-2026)
  • Table 250. Europe Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 251. Europe Custom Antibody, by Service USD Million (2021-2026)
  • Table 252. Europe Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 253. Europe Custom Antibody, by Source USD Million (2021-2026)
  • Table 254. Germany Custom Antibody, by Type USD Million (2021-2026)
  • Table 255. Germany Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 256. Germany Custom Antibody, by Service USD Million (2021-2026)
  • Table 257. Germany Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 258. Germany Custom Antibody, by Source USD Million (2021-2026)
  • Table 259. France Custom Antibody, by Type USD Million (2021-2026)
  • Table 260. France Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 261. France Custom Antibody, by Service USD Million (2021-2026)
  • Table 262. France Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 263. France Custom Antibody, by Source USD Million (2021-2026)
  • Table 264. Italy Custom Antibody, by Type USD Million (2021-2026)
  • Table 265. Italy Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 266. Italy Custom Antibody, by Service USD Million (2021-2026)
  • Table 267. Italy Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 268. Italy Custom Antibody, by Source USD Million (2021-2026)
  • Table 269. United Kingdom Custom Antibody, by Type USD Million (2021-2026)
  • Table 270. United Kingdom Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 271. United Kingdom Custom Antibody, by Service USD Million (2021-2026)
  • Table 272. United Kingdom Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 273. United Kingdom Custom Antibody, by Source USD Million (2021-2026)
  • Table 274. Netherlands Custom Antibody, by Type USD Million (2021-2026)
  • Table 275. Netherlands Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 276. Netherlands Custom Antibody, by Service USD Million (2021-2026)
  • Table 277. Netherlands Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 278. Netherlands Custom Antibody, by Source USD Million (2021-2026)
  • Table 279. Rest of Europe Custom Antibody, by Type USD Million (2021-2026)
  • Table 280. Rest of Europe Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 281. Rest of Europe Custom Antibody, by Service USD Million (2021-2026)
  • Table 282. Rest of Europe Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 283. Rest of Europe Custom Antibody, by Source USD Million (2021-2026)
  • Table 284. MEA Custom Antibody, by Country USD Million (2021-2026)
  • Table 285. MEA Custom Antibody, by Type USD Million (2021-2026)
  • Table 286. MEA Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 287. MEA Custom Antibody, by Service USD Million (2021-2026)
  • Table 288. MEA Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 289. MEA Custom Antibody, by Source USD Million (2021-2026)
  • Table 290. Middle East Custom Antibody, by Type USD Million (2021-2026)
  • Table 291. Middle East Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 292. Middle East Custom Antibody, by Service USD Million (2021-2026)
  • Table 293. Middle East Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 294. Middle East Custom Antibody, by Source USD Million (2021-2026)
  • Table 295. Africa Custom Antibody, by Type USD Million (2021-2026)
  • Table 296. Africa Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 297. Africa Custom Antibody, by Service USD Million (2021-2026)
  • Table 298. Africa Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 299. Africa Custom Antibody, by Source USD Million (2021-2026)
  • Table 300. North America Custom Antibody, by Country USD Million (2021-2026)
  • Table 301. North America Custom Antibody, by Type USD Million (2021-2026)
  • Table 302. North America Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 303. North America Custom Antibody, by Service USD Million (2021-2026)
  • Table 304. North America Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 305. North America Custom Antibody, by Source USD Million (2021-2026)
  • Table 306. United States Custom Antibody, by Type USD Million (2021-2026)
  • Table 307. United States Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 308. United States Custom Antibody, by Service USD Million (2021-2026)
  • Table 309. United States Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 310. United States Custom Antibody, by Source USD Million (2021-2026)
  • Table 311. Canada Custom Antibody, by Type USD Million (2021-2026)
  • Table 312. Canada Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 313. Canada Custom Antibody, by Service USD Million (2021-2026)
  • Table 314. Canada Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 315. Canada Custom Antibody, by Source USD Million (2021-2026)
  • Table 316. Mexico Custom Antibody, by Type USD Million (2021-2026)
  • Table 317. Mexico Custom Antibody, by End-Users USD Million (2021-2026)
  • Table 318. Mexico Custom Antibody, by Service USD Million (2021-2026)
  • Table 319. Mexico Custom Antibody, by Research Area USD Million (2021-2026)
  • Table 320. Mexico Custom Antibody, by Source USD Million (2021-2026)
  • Table 321. Research Programs/Design for This Report
  • Table 322. Key Data Information from Secondary Sources
  • Table 323. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Custom Antibody: by Type USD Million (2015-2020)
  • Figure 5. Global Custom Antibody: by End-Users USD Million (2015-2020)
  • Figure 6. Global Custom Antibody: by Service USD Million (2015-2020)
  • Figure 7. Global Custom Antibody: by Research Area USD Million (2015-2020)
  • Figure 8. Global Custom Antibody: by Source USD Million (2015-2020)
  • Figure 9. South America Custom Antibody Share (%), by Country
  • Figure 10. Asia Pacific Custom Antibody Share (%), by Country
  • Figure 11. Europe Custom Antibody Share (%), by Country
  • Figure 12. MEA Custom Antibody Share (%), by Country
  • Figure 13. North America Custom Antibody Share (%), by Country
  • Figure 14. Global Custom Antibody share by Players 2020 (%)
  • Figure 15. Global Custom Antibody share by Players (Top 3) 2020(%)
  • Figure 16. Global Custom Antibody share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Merck Group (Germany) Revenue: by Geography 2020
  • Figure 24. Abcam plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Abcam plc (United Kingdom) Revenue: by Geography 2020
  • Figure 26. Cell Signaling Technology, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Cell Signaling Technology, Inc. (United States) Revenue: by Geography 2020
  • Figure 28. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Agilent Technologies, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. GenScript (United States) Revenue, Net Income and Gross profit
  • Figure 31. GenScript (United States) Revenue: by Geography 2020
  • Figure 32. BioLegend, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. BioLegend, Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Rockland Immunochemicals (United States) Revenue, Net Income and Gross profit
  • Figure 35. Rockland Immunochemicals (United States) Revenue: by Geography 2020
  • Figure 36. ProMab Biotechnologies (United States) Revenue, Net Income and Gross profit
  • Figure 37. ProMab Biotechnologies (United States) Revenue: by Geography 2020
  • Figure 38. Global Custom Antibody: by Type USD Million (2021-2026)
  • Figure 39. Global Custom Antibody: by End-Users USD Million (2021-2026)
  • Figure 40. Global Custom Antibody: by Service USD Million (2021-2026)
  • Figure 41. Global Custom Antibody: by Research Area USD Million (2021-2026)
  • Figure 42. Global Custom Antibody: by Source USD Million (2021-2026)
  • Figure 43. South America Custom Antibody Share (%), by Country
  • Figure 44. Asia Pacific Custom Antibody Share (%), by Country
  • Figure 45. Europe Custom Antibody Share (%), by Country
  • Figure 46. MEA Custom Antibody Share (%), by Country
  • Figure 47. North America Custom Antibody Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Merck Group (Germany)
  • Abcam plc (United Kingdom)
  • Cell Signaling Technology, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • GenScript (United States)
  • BioLegend, Inc. (United States)
  • Rockland Immunochemicals (United States)
  • ProMab Biotechnologies (United States)
Additional players considered in the study are as follows:
Innovagen AB (Sweden) , ProteoGenix (United States) , Abgent (United States)
Select User Access Type

Key Highlights of Report


Jul 2021 216 Pages 86 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Custom Antibody Market Quantitative research analysis
Global Custom Antibody Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Custom Antibody study can be customized to meet your requirements. The market size breakdown by type [Monoclonal, Polyclonal and Recombinant], by end use application [].
The Custom Antibody Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Custom Antibody market is expected to see growth rate of 8.88%.

Know More About Global Custom Antibody Market Report?

Have a Query? Click Here

Other Related Reports

Pemetrexed Drug Comprehensive Study by Application (Pleural mesothelioma, Lung Cancer, Colorectal Cancer, Stomach Cancer, Breast Cancer), Distribution Channel (Online, Offline), Strength (100 mg lyop...
$ 3450
Trazodone Hydrochloride Comprehensive Study by Type (Tablet, Capsule), Application (Antidepression, Anxiolytic, Hypnotic, Others), (), Depression (Major Depression, Bipolar Disorder, Psychotic Depr...
$ 3650
Pain Management Drugs Comprehensive Study by Type (Generic Opioids, Branded Opioids), Application (Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathi...
$ 3750
Acromegaly and Gigantism Drugs Comprehensive Study by Type (Somatostatin Analogs, GH Receptor Antagonists, Dopamine Agonists, Recombinant Human IGF-1), Distribution Channel (Retail Pharmacies, Hospit...
$ 3350
DPT Vaccines Comprehensive Study by Type (DPaT, DTwP, Tdap), Application (Diphtheria, Tetanus, Pertussis, Others), Vaccine Type (Whole-Cell Vaccine, Acellular Vaccine), End-User (Adult, Pediatric) Pl...
$ 3500
Pharmaceutical Hot Melt Extrusion Comprehensive Study by Type (Single Screw Extruder, Twin Screw Extruder, Laboratory Extruder, RAM Extruder), End User (Research Laboratory, Contract Manufacturing Or...
$ 3350